Cellular senescence suppresses cancer by stably arresting the proliferation of damaged cells 1 . Paradoxically, senescent cells also secrete factors that alter tissue microenvironments 2 . The pathways regulating this secretion are unknown. We show that damaged human cells develop persistent chromatin lesions bearing hallmarks of DNA double-strand breaks (DSBs), which initiate increased secretion of inflammatory cytokines such as interleukin-6 (IL-6). Cytokine secretion occurred only after establishment of persistent DNA damage signalling, usually associated with senescence, not after transient DNA damage responses (DDRs). Initiation and maintenance of this cytokine response required the DDR proteins ATM, NBS1 and CHK2, but not the cell-cycle arrest enforcers p53 and pRb. ATM was also essential for IL-6 secretion during oncogene-induced senescence and by damaged cells that bypass senescence. Furthermore, DDR activity and IL-6 were elevated in human cancers, and ATM-depletion suppressed the ability of senescent cells to stimulate IL-6-dependent cancer cell invasiveness. Thus, in addition to orchestrating cell-cycle checkpoints and DNA repair, a new and important role of the DDR is to allow damaged cells to communicate their compromised state to the surrounding tissue.
1
. Senescent cells also develop a complex senescence-associated secretory phenotype (SASP), in culture and in vivo [3] [4] [5] [6] . The SASP can disrupt normal mammary differentiation 4, 7 , promote endothelial cell invasion 8 , stimulate cancer cell growth and invasion in culture and can promote tumour growth in vivo [4] [5] [6] . Additionally, some SASP factors can reinforce the senescence arrest by autocrine or paracrine mechanisms [9] [10] [11] [12] . The SASP factors IL-6 and IL-8 are of particular interest: these cytokines initiate inflammatory responses, such as those associated with normal healing in damaged tissues, as well as many age-related pathologies, including cancer 13 . Normal cells undergo senescence in response to severe or irreparable DNA damage, especially DNA DSBs. One of the first proteins to respond to DSBs is ATM (ataxia telangiectasia mutated), a member of the phosphoinositide-3 kinase-like kinase (PIKK) family. ATM substrates include H2AX, a nucleosomal histone variant, and p53 binding protein-1 (53BP1), which facilitates checkpoint activation and repair. Phosphorylated H2AX (γH2AX) and 53BP1 rapidly localize to DSBs, forming characteristic foci. ATM also phosphorylates the DDR kinase CHK2 (checkpoint kinase-2), which promotes growth arrest; NBS1 (Nijmegen breakage syndrome), a member of the MRN (MRE11-RAD51-NBS1) complex that reinforces the DDR and participates in DNA repair; and p53, a tumour suppressor and transcriptional regulator that orchestrates repair and cell-cycle arrest (reviewed in ref. 14) . DSBs that cannot be repaired (for example, uncapped telomeres) cause constitutive DDR signalling, prolonged p53-dependent growth arrest and eventually an essentially irreversible senescence arrest 1, 15 . Despite understanding much about how the senescence arrest is initiated and maintained, little is known about how the SASP is regulated. We recently showed that the SASP is correlated with genotoxic stress, suggesting it is controlled by DDR signalling 6 . However, p53, a key DDR effector, was not required for the SASP 6 , raising the possibility that the SASP and DDR are not linked. Here, we investigate whether DDR components upstream of p53 regulate the SASP, focusing on two principal SASP factors, the inflammatory cytokines IL-6 and IL-8.
We synchronously damaged DNA in HCA2 human diploid fibroblasts using ionizing radiation (X-ray). A relatively low dose (0.5 Gy) rapidly induced several 53BP1 foci in all nuclei and engaged the DDR, as indicated by p53 Ser 15 phosphorylation and upregulation of p21, a cell-cycle inhibitor and p53 target (Fig. 1a, b) . Both indicators returned to near baseline levels within 10 h, as cells resolved the 53BP1 foci (Fig. 1a-c ) and resumed growth ( Supplementary Information, Fig. S1a, b) . A senescence-inducing dose (10 Gy) also triggered a rapid DDR; however, several 53BP1 foci failed to resolve and increased in size (Fig. 1a-c) . These persistent DNA damage foci (PDDF) contained γH2AX, and remained for days ( Supplementary  Information, Fig. S1d ) and months (data not shown), while cells remained arrested ( Supplementary Information, Fig. S1a, b) . PDDF also contained activated (phosphorylated) ATM and ATM/ATR substrates (Fig. 1d) . Therefore, a low dose of radiation induced a transient DDR from which cells recovered, whereas a high dose generated PDDF, localized but constitutive DDR signalling, and senescence.
Low-dose radiation did not increase IL-6 secretion in HCA2 cells, which remained at control levels. In contrast, a high dose increased IL-6 and IL-8 secretion 5-to 6-fold within 2-4 days, reaching replicatively senescent levels within 3-5 days ( Fig. 1e; Supplementary Information,  Fig. S1c ). Human WI-38 fibroblasts behaved similarly (data not shown). Thus, DNA damage and the DDR alone do not induce inflammatory cytokine secretion; rather, secretion develops after a delay, when the damage is sufficient to generate PDDF and persistent DDR signalling.
To investigate this further, we used lentiviruses to express p16 INK4a , a cyclin-dependent kinase inhibitor that causes senescence arrest 1 . Infected cells showed few PDDF and secreted little IL-6 ( Fig. 1f, g ; Supplementary  Information, Fig. S1e ), yet expressed other senescence markers, including increased intracellular reactive oxygen species ( Supplementary  Information, Fig. S1g-j) . Conversely, more than two PDDF and a high level of IL-6 secretion was evident in cells induced to senesce by conditions that caused DNA damage (Fig. 1f, g ). IL-8 secretion behaved similarly to IL-6 secretion ( Supplementary Information, Fig. S1k ).
HCA2 fibroblasts undergo p53-dependent replicative senescence owing to short (dysfunctional) telomeres ( Supplementary Information, Fig. S2a ) 1, 16 . Accordingly, early passage cells had few PDDF, whereas senescent cells had three or more (P < 10 -9 , two-tailed student's unpaired t-test; Supplementary  Information, Fig. S2b, c) . As cells proliferated, PDDF accumulated gradually (Fig. 2a, top) , DNA synthesis declined and IL-6 (Fig. 2a, bottom) and IL-8 ( Supplementary Information, Fig. S2d ) secretion increased. IMR-90 human fibroblasts behaved similarly ( Supplementary Information, Fig. S2e ). We used immunostaining to assess cytokine expression, growth arrest (absence of DNA synthesis) and PDDF in single cells within senescing HCA2 populations. Proliferating cells can acquire dysfunctional telomeres before arrested growth 17 . Indeed, PDDF-positive cells did not necessarily fail to synthesize DNA, although they synthesized DNA less frequently than cells without PDDF (Fig. 2b, c) . IMR90 fibroblasts behaved similarly ( Supplementary  Information, Fig. S2f ). Furthermore, in late passage populations, many cells that synthesized DNA also showed robust immunostaining for IL-6 ( Fig. 2d) and MMP3 (matrix metalloproteinase 3), another SASP factor ( Supplementary Information, Fig. S2g ). Together with the p16
INK4a results (Fig. 1f, g ), these findings suggest that PDDF, rather than senescence arrest per se, correlate with inflammatory cytokine secretion.
To corroborate this idea, we suppressed telomeric PDDF in early passage HCA2 cells by expressing telomerase (the hTERT catalytic subunit) (a) HCA2 fibroblasts were untreated, irradiated with 0.5 or 10 Gy and allowed to recover. Cells were fixed and stained for 53BP1 foci (red) at the indicated intervals after irradiation. (b) Whole cell lysates were prepared at the indicated intervals after irradiation and analysed by western blotting for the indicated proteins. C, control. P-p53, Ser 15-phosphorylated p53. (c) HCA2 cells were irradiated with 0.5 or 10 Gy and allowed to recover for the indicated intervals before being fixed and stained for 53BP1 foci. Nuclei with three or more foci were quantified. (d) HCA2 cells were irradiated with 10 Gy and analysed 6 days later for γ-H2AX (red) and the Ser/Thr phosphorylated ATM/ ATR substrate motif (p-STK Sub; green; top panels), or 53BP1 (red) and activated (phosphorylated) ATM (p-ATM; green; bottom panels). The merged red and green channels show colocalization in yellow. (e) HCA2 cells were irradiated with 0.5 or 10 Gy, and IL-6 secretion was assessed using ELISA Conditioned media from the cell populations described in f were collected over 24 h and analysed for IL-6 by ELISA. The data are reported as fold increase in secretion relative to untreated control cells, and are plotted on a log scale (n = number of cell populations analysed). Data are mean ± s.d. from three independent measurements in c and e-g. for 20 population doublings (PDs). In contrast to control cells (Fig. 2a , compare PD 25-40 with PD 40-60), hTERT-expressing cells showed slightly decreased numbers of PDDF but no increase in IL-6 secretion (Fig. 2e) . Moreover, when hTERT-expressing cells exceeded the PD level at which unmodified cells completely senesce (PD71-75), PDDF and IL-6 secretion were similar to, or lower than, those in early passage cells (Fig. 2e) . To confirm that rescued telomere dysfunction, rather than hTERT per se, caused the decline in PDDF and IL-6 secretion, we induced senescence in PD50 hTERT-expressing cells by X-irradiation. Radiation generated PDDF and greatly increased IL-6 secretion in these cells (Figs 1f, g and 2f) . Thus, hTERT reduced telomeric PDDF, but not radiation-induced PPDF (most of which are presumably non-telomeric). These results support the idea that PDDF and persistent DDR signalling are responsible for inflammatory cytokine secretion.
To determine whether the tumour suppressors p53 and pRb are required for IL-6 secretion, we used lentiviruses to express a short-hairpin RNA against p53 (sh53), GSE22 (a dominant peptide suppressor of p53 activity) 1 or SV-40 T antigen (SV40LT, which inactivates p53 and pRb) 1 , in replicatively senescent HCA2 cells. As expected for HCA2 cells, which express low levels of endogenous p16
INK4a
, p53 inactivation reversed the senescence growth-arrest and drove cells into crisis ( Supplementary  Information, Fig. S2a and data not shown) 1 . At 3-4 PDs after infection, IL-6 secretion did not decline, but increased (Fig. 3a) . Thus, neither p53, pRB nor senescence arrest was required for IL-6 secretion.
Similarly, we inactivated p53 ( Supplementary Information, Fig. S3a ) in early passage HCA2 cells using retrovirally-delivered GSE22. There was no change in either PDDF or IL-6 secretion after 5 PDs (Fig. 3b) . However, 15 PDs after p53 inactivation, both IL-6 secretion and PDDF increased markedly (Fig. 3b) . These increases also occurred after p53 depletion by shp53 (Fig. 3c ), although they were more modest (perhaps owing to residual p53 levels; Supplementary Information, Fig. S3b ). Thus, p53 was not required to initiate PDDF-driven cytokine secretion, and loss of p53 function in proliferating cells gradually increased the levels of both PDDF and secreted IL-6.
To determine the contribution of telomeric PDDF to the increased IL-6 secretion by p53-deficient cells, we expressed hTERT in GSE22-expressing cells that had developed high levels of IL-6 secretion. Expression of hTERT reduced both PDDF and IL-6 secretion (Fig. 3d) , as it did in cells expressing wild-type p53 ( Supplementary Information, Fig. S3c ). Cells expressing hTERT and GSE22 did not grow faster than cells expressing GSE22 only, were pulsed with BrdU for 24 h and fixed. Single cells were analysed by immunofluorescence for intracellular IL-6 (green) and BrdU incorporation (red). (e) Cells were infected with a retrovirus expressing hTERT, selected and cultured for the indicated doublings (PD after infection). At the indicated PDs, cells were analysed for three or more 53BP1 foci (top panels) or IL-6 secretion (lower panels), as described for panel a. (f) Early passage HCA2 or HCA2 cells expressing hTERT were irradiated with 10 Gy, allowed to recover for 8 days, and analysed for 53BP1 foci (top panel) and IL-6 secretion as described for panel a. IL-6 secretion is reported as the fold increase compared with unirradiated control cells. There was an apparent reduction that was not statistically significant in 53BP1 foci and a slight reduction in IL-6 levels (P = 0.036, two-tailed unpaired student's t-test) in hTERT cells. Data are mean ± s.d. in a, c, e and f, from three independent measurements in c, e and f. Numerical values are given above the bars in e and f (lower panels).
ruling out the possibility that hTERT enabled the proliferation of a few clones with serendipitously low PDDF and/or IL-6 secretion. Expression of hTERT only partially reduced IL-6 and PDDF levels in p53-deficient cells, suggesting that dysfunctional or near-dysfunctional telomeres account for some, but not all, of the PDDF in proliferating p53-deficient cells ( Supplementary Information, Fig. S3d ). Nevertheless, even in actively dividing p53-deficient cells, reduced PDDF numbers coincided with reduced IL-6 secretion.
ATM is a key responder to DNA damage and a prominent component of PDDF (Fig. 1d) . We tested the idea that PDDF drive cytokine secretion by providing sustained DDR signalling. We infected HCA2 cells with lentiviruses encoding shRNAs against green fluorescent protein (shGFP, control) or ATM (shATM; Fig. 4a ). ATM depletion (80-90%) prevented the increased IL-6 secretion that normally occurs 9-10 days after 10 Gy of X-irradiation (Fig. 4b) . We obtained similar results using WI-38 fibroblasts ( Supplementary Information, Fig. S3e, f) . Additionally, ATM depletion in already replicatively senescent cells effectively abolished IL-6 secretion (Fig. 4c) . Finally, primary A-T fibroblasts from patients carrying an inactivating mutation in ATM had low but detectable basal IL-6 secretion levels and completely lacked the 2-3 day and 9-10 day cytokine responses following 10 Gy X-irradiation (Fig. 4d) .
ATM shares many substrates with ATR, another PIKK, which is preferentially activated when cells are damaged during S phase 14 . To determine whether ATR is important for the DNA damage cytokine response, we measured IL-6 secretion by primary fibroblasts from a Seckel syndrome patient. These cells have almost undetectable ATR levels owing to a splicing mutation. They also showed relatively high basal levels of IL-6 secretion, but this secretion increased after X-irradiation (10 Gy; Fig. 4e ). The magnitude of the increase was smaller than that in wild-type cells, possibly because IL-6 secretion is already high in these cells or because ATR partly contributes to the cytokine response. Whatever the case, these findings support the idea that persistent DDR signalling drives IL-6 secretion and that ATM is essential, whereas ATR might contribute to this response.
To determine whether other DDR components are necessary for the DNA damage cytokine response, we depleted cells of either NBS1, an MRN component required for optimal ATM activity, or CHK2, another DDR kinase and a downstream target of ATM (Fig. 4f, g ). Similarly to ATM depletion, NBS1 or CHK2 depletion essentially prevented the increased IL-6 secretion following 10 Gy X-irradiation and abolished the high IL-6 secretion by already senescent cells (Fig. 4h, i) . Thus, three major DDR components (ATM, NBS1 and CHK2) are essential for both establishing and maintaining the cytokine response to DNA damage.
To identify which SASP components respond to DDR signalling, we used antibody arrays to interrogate 120 cytokines and other factors secreted by senescent HCA2 cells. We focused on 16 factors that were significantly modulated by X-irradiation, most being upregulated (Fig. 5a ). We compared the secretion levels of these 16 factors in control and ATM-depleted cells induced to senesce by X-irradiation (10 Gy). ATM depletion reduced the secretion of 7 of these 16 SASP factors, supressing IL-6 secretion 50-fold and IL-8 secretion 10-fold. Nine factors were unchanged by ATM depletion (≤ 1.4-fold the secretion level of non-depleted cells; Fig.5b ). Thus, ATM signalling does not regulate the entire SASP, but is required for a subset of SASP components, including the major inflammatory cytokines.
The SASP can promote cancer cell invasion, largely due to secreted IL-6 (ref. 6 ). To determine the biological significance of the DDR-dependent cytokine response, we used conditioned medium from control and senescent (X-irradiated) ATM-depleted cells in invasion assays. As expected, human breast cancer cells (T47D) were stimulated to invade a basement membrane when exposed to conditioned medium from control senescent cells (Fig. 5c ). This stimulatory activity was deficient, however, in conditioned medium from ATM-depleted senescent cells, but it was largely restored by supplementing this conditioned medium with recombinant IL-6. Thus, DDRdependent SASP factors can have a significant biological consequence.
Persistent DDR signalling has been detected in vivo in premalignant and malignant lesions in human breast, lung, skin, bladder and colon 18, 19 . To model premalignant cells, we used p53-defective HCA2-GSE22 fibroblasts after they spontaneously developed PDDF and increased IL-6 secretion (Fig. 3b) . ATM depletion in these cells reduced IL-6 secretion by 70% ( Supplementary Information, Fig. S3g ), supporting the idea that DDR signalling can drive inflammatory cytokine secretion during neoplastic transformation. To determine whether IL-6 secretion and DDR signalling are linked in vivo, we used immunostaining to assess DDR and ATM activity, and IL-6 expression in human breast cancer specimens. Both phosphorylated ATM/ATR substrates and IL-6 levels were significantly elevated in invasive ductal carcinomas compared with normal human breast tissue ( Fig. 5d; Supplementary Information, Fig. S4 ). Thus, DDR signalling and inflammatory cytokine secretion correlated in vivo.
Inflammatory cytokine secretion is also a feature of cells that senesce due to oncogene activation (oncogene-induced senescence, OIS) in culture 6, 11, 12 , and of preneoplastic lesions in human colon, which presumably harbour activated oncogenes in vivo 11 . To determine whether DDR signalling is required for OIS-induced IL-6 secretion, we used lentiviral vectors to simultaneously express oncogenic RAS and shATM in HCA2 cells ( Supplementary Information, Fig. S3h ). ATM-deficient cells undergo DDR signalling is required for the cytokine response to PDDF (a) HCA2 cells were infected with lentiviruses expressing shRNAs against GFP (control, shGFP3) or ATM (shATM-11, -12 or -13) and allowed to recover for 5 days. Whole cell lysates were analysed by western blotting for the indicated proteins. Ponceau staining shows the total proteins. (b) HCA2 cells were infected as above and irradiated with 10 Gy X-Ray. After 9 days, conditioned media were collected over 24 h and assessed for IL-6 by ELISA. IL-6 secretion is reported as fold change over unirradiated shGFP control. ND, not detected. (c) Replicatively senescent HCA2 cells were infected as above and allowed to recover for 6 days. Conditioned media were collected over 24 h and assessed for IL-6 secretion (reported as fold change over shGFP control). (d) A-T cells were irradiated with 10 Gy and allowed to recover for 2 or 10 days. Conditioned media were collected over 24 h, and analysed for IL-6 by ELISA (reported as fold increase compared to unirradiated A-T cells; numerical values are given above the bars). (e) Seckel syndrome cells were irradiated and analysed for IL-6 as described above for A-T cells. (f, g) HCA2 cells were infected with lentiviruses expressing shRNAs against GFP (control, shGFP3), NBS1 (shNBS1-1, -2, -6, or -7) or CHK2 (shCHK2-2, -12 or -13), selected and allowed to recover for 7 days. Whole cell lysates were analysed by western blotting for the indicated proteins. The arrow indicates CHK2; NS indicates a non-specific band detected by the antibody. (h) HCA2 cells from f and g with the indicated shRNA-expressing lentiviruses were irradiated with 10 Gy X-Ray. After 2 days, conditioned media were collected over 24 h and assessed for IL-6 using ELISA (reported as fold change over unirradiated shGFP control). (i) Replicatively senescent HCA2 cells were infected with indicated shRNA-expressing lentiviruses and allowed to recover for 6 days. Conditioned media were collected over 24 h and assessed for IL-6 (reported as fold change over shGFP control). Data are mean ± s.d. from three independent measurements in c-e, h and i. Numerical values are given above the bars in b-e, h and i.
rapid replicative senescence 20 but undergo OIS depending on the oncogene and context [21] [22] [23] . As observed previously 21 , oncogenic RAS-expressing fibroblasts underwent OIS regardless of their ATM status (Fig. 5e) . Additionally, the RAS-expressing ATM-deficient cells developed both a typical OIS morphology (enlargement and vacuolization) and 53BP1 foci that lacked detectable activated-ATM (Fig. 5f-g ). Oncogenic RAS also caused OIS and 53BP1 foci in primary A-T cells (Fig. 5f and data not shown). Therefore, ATM depletion had no discernible effects on OIS phenotypes, including growth arrest and PDDF. However, ATM depletion effectively prevented OIS-driven IL-6 secretion in both A-T (Fig. 5h ) and HCA2 cells (Fig. 5i) . Thus, ATM controls IL-6 secretion caused by several forms of damage-induced senescence, including OIS, which is known to occur in vivo (reviewed in ref. 14) .
Our findings identify a new response to persistent DNA damage -the secretion of factors that allow damaged cells to communicate with their microenvironment. This response is associated with cellular senescence, but also occurs in damaged cycling cells that are near, or have bypassed, senescence. Our results suggest a model in which mild genotoxic stress (for example, 0.5 Gy of X-irradiation, which generates about 17 DSBs per nucleus) 24 causes a DDR, damage foci, transient cell-cycle arrest and repair, but does not induce inflammatory cytokine secretion ( Supplementary Information,  Fig. S3i ). More severe genotoxic stress (for example, dysfunctional telomeres . Signals above the PRE baseline are in yellow, signals below the baseline, in blue. Factors that differed significantly between PRE and XRA cells are displayed (P < 0.05, student's unpaired t-test). (b) SASP factors in panel a were analysed in X-irradiated, ATM-depleted cells (XRAshATM) and compared with irradiated-senescent HCA2-shGFP cells (XRA). Changes are reported as XRA (shATM) divided by XRA levels. Signals below the XRA baseline are in blue, factors not substantially modulated by ATMdeficiency, in grey. (c) T47D invasion stimulated by presenescent (PRE) HCA2 conditioned medium was given a value of 1. Compared with PRE and serumfree (SF) media, invasion was significantly (P < 0.05) stimulated by 10% serum (FBS), and conditioned medium from irradiated HCA2 (XRA), HCA2-shGFP (XRA-shGFP) and HCA2-shATM cells plus IL-6 (XRA-shATM+IL-6), but not by conditioned medium from HCA2-shATM cells (XRA-shATM; n = number of samples analysed). Recombinant IL-6 was added to levels detected by ELISA in XRA-shGFP cells (3ng ml or 10 Gy of X-irradiation) produces PDDF and persistent DDR signalling, which establishes and maintains the p53-dependent senescence growtharrest. After several days, this DDR signalling also initiates the p53-independent cytokine response through ATM, NBS1 and CHK2. Cells deficient in p53 can initiate the cytokine response in the absence of growth arrest. In contrast, cells induced to senesce by p16
INK4a expression, but lacking DNA damage, do not initiate a cytokine response. Thus, the DDR can independently control at least two important phenotypes: the p53-dependent growth arrest and senescence-associated extracellular inflammatory signalling. Our results suggest that functions previously attributed to growth arrested senescent cells, specifically their ability to perturb the local microenvironment, can be acquired by damaged cells, whether they are senescent or competent to proliferate.
DDR signalling drives only a subset of SASP factors, but these include the potent inflammatory cytokines IL-6 and IL-8. The cytokine IL-6 was particularly important for the ability of senescent cells to promote cancer cell invasion. Hallmarks of persistent DNA damage are seen in pre-cancerous and malignant lesions 18, 19 , which are presumed to harbour activated oncogenes, and in aging mammalian tissues 25, 26 . Our results suggest DDR signalling drives the inflammation that is also a hallmark of premalignant, malignant and aging tissues. During aging, damaged cells might cause or contribute to tissue dysfunction, including dysfunctional stem-cell niches 27 . In cancer, such cells might promote inflammation, angiogenesis or other phenotypes of cancer progression 2 . Why do damaged cells mount a cytokine response? One demonstrated possibility is to reinforce a growth arrest [9] [10] [11] [12] . Presenescent levels of cytokine receptors are apparently sufficient to contribute to the rapid DDR growth arrest 12 . However, early experiments showed that senescent cells do not secrete factors that strongly inhibit the growth of nearby presenescent cells 28 . Thus, cytokines might reinforce a senescence arrest only when cells are moderately damaged or near senescent. The cytokine response might also function in a paracrine manner [4] [5] [6] [7] [8] to suppress or promote the proliferation of neighbouring cells in damaged tissues, allowing damaged cells to communicate their compromised state to surrounding cells and perhaps mobilize the immune system for their clearance. In support of this idea, tumours induced to senesce by genetic manipulation or chemotherapy regress, showing evidence of activated innate immune cells 29 , and senescent cells in injured liver seem to limit fibrosis before being cleared by the immune system 30 . In this context, the delayed cytokine response to severe DNA damage could allow cells to attempt DNA repair before generating potent immune-mobilizing signals.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturecellbiology/. ) and streptomycin/penicillin (100 U ml -1 ). Early passage is defined as having completed < 35 PD and having a 24 h BrdU (bromodeoxyuridine) labelling index of > 75%. Cell populations were considered replicatively senescent when they had 24 h labelling indices of < 5%. Primary A-T (AT2SF) and Seckel syndrome (GM09812) fibroblasts were obtained from the Coriell Institute (NJ, USA) and used at early passages (24 h BrdU labelling index of > 75%). Cumulative PDs of primary cells were determined as follows: current PD = last PD + log 2 (cell number per cells seeded). 293FT packaging cells (Invitrogen) were used to generate lentiviruses and PT67 cells (Clontech) were used to generate retroviruses 1 .
Viruses and infections.
Retroviruses or lentiviruses encoding dominant-negative TIN2 (TIN2-15C), GSE22, SV40LT, p16
INK4A
, oncogenic RAS V12 and hTERT have been described previously 1, 31 . TIN2DN-ires-eGFP, eGFP, p16 INK4A and RAS V12 were subcloned into a lentiviral vector with puromycin selection (670-1). Custom RNAi short hairpins were subcloned into vectors 749-3 (shp53, zeocin selection) and W17-1 (shGFP2 and shATM2, hygromycin selection) (E.C. et al., submitted; for transgene expression see Supplementary Information, Fig. S5a, b) . Lentiviruses encoding shRNAs against GFP, ATM, CHK2 and NBS1 were purchased from Open Biosystems. Virus titres were adjusted to infect 95-99% of cells 1 .
shRNA target sequences. The target sequences used were: shp53, target 5-GACTCCAGTGGTAATCTAC-3; shATM2, target 5-TGAAGATGGTGCTCATAAA-3; shATM11, #TRCN0000039948 target 5-CCTTTCATTCAGCCTTTAGAA-3; shATM12, #TRCN0000038654 target 5-CCTGCCAACATACTTTAAGTA-3; shATM13, #TRCN0000010299 target 5-TGATGGTCTTAAGGAACATCT-3; shGFP2, target 5-GCTGGAGTACAACTACAAC-3; shGFP3, #RHS4459 (Open Biosystems); shCHK2-2, #TRCN0000039946 target 5-GCCAATCTTGAATGTGTGAAT-3; shCHK2-12, #TRCN0000010314 target 5-ACTCCGTGGTTTGAACACGAA-3; shCHK2-13, #TRCN0000039943 target 5-CTCCGTGGTTTGAACACGAA-3; shNBS1-1, #TRCN0000040134 target 5-GCCGAAATCATGCTGTGTTAA-3; shNBS1-2, #TRC0000010392 target 5-CAAGCTATATTGCAACTTGGA-3; shNBS1-6, #TRC0000010393 target 5-AAGAGTGGCTAAGGCAGGAA-3; shNBS1-7, #TRCN0000040133 target 5-GCTTATTTAGAGTCCTAGTTT-3.
Irradiation. Cells were X-irradiated with total doses of either 0.5 Gy or 10 Gy at rates equal to or above 0.75 Gy min -1 using a Pantak X-ray generator (320 kV per 10 mA with 0.5 mm copper filtration).
Immunofluorescence. Cells were cultured in 4-well chamber-slides (Nunc), fixed in formalin for 10 min at room temperature and permeabilized in PBS containing 0.2% Triton X-100 for 10 min. Slides were blocked for 1 h in PBS containing 1% BSA and 4% normal donkey serum. Primary antibodies were diluted in blocking buffer and incubated with fixed cells overnight at 4 °C. The cells were washed, incubated with secondary antibodies for 1 h at room temperature, washed again and mounted with slow-fade gold (Molecular Probes). Images were acquired on an Olympus BX60 fluorescence microscope with Spotfire 3.2.4 software (Diagnostics Instruments) and processed with Photoshop CS2 software (Adobe).
Frozen section tissue arrays. Tissue arrays were purchased from Biochain Institute Inc. (arrays #T6235700 and #B112136). The array #T6235700 contains 2 samples, one normal and one cancer breast tissue (invasive ductal carcinoma). The array #B112136 contains 3 normal breast and 37 invasive ductal carcinoma tissue sections. One normal section on #B112136 was discarded because it had no ducts and one cancer tissue was discarded because it was an obvious outlier, showing IL-6 staining that was extremely strong. Note that when this sample was included in the statistical analysis, the differences between normal and tumour samples remained statistically significant, but it could be argued that this single outlier drove the significance between the normal and cancer samples and we therefore removed it. From the 3 normal samples used, 7 normal ducts were imaged from each section and used as individual data points to compare with the cancer tissues (a total of 21 normal duct data points equally weighted from 3 individual patients). From the 37 cancer samples used, one representative field per cancer was imaged and quantified.
Tissue immunofluorescence quantification. Frozen slides were brought to room temperature and processed as described for immunofluorescence. Representative images of each tissue sample were quantified using CellProfiler (free, open-access cell image analysis software; www.cellprofiler.org). Briefly, the total area of DAPI staining in each image was calculated using a per-image threshold to exclude background pixels. This area was then translated into a binary image and used to mask the phosphorylated ATM/ATR substrate channel (pSTK) so that signal from only within the DAPI stained region was counted. The total red signal inside the DAPI stained region was integrated and divided by the total DAPI area to give the final phosphorylated ATM/ATR substrate per tissue sample, normalized to the nuclear area. IL-6 staining is primarily non-nuclear, so the DAPI mask could not be used. Instead, the total IL-6 signal was integrated over the unmasked image and divided by the total DAPI area to give the final IL-6 levels per tissue sample, normalized to the nuclear area.
Antibodies. Primary antibodies targeted 53BP1 (Bethyl, BL182; 1:1,000), γ-H2AX (Upstate, JBW301; 1:1,000), p53 (Oncogene Research Products, DO-1; 1:1,000), Ras (BD Biosciences, 610001; 1:500), p16 (Neomarkers, JC8; 1:500), p21 (BD Biosciences, 556430; 1:500), actin (Chemicon, MAB3128; 1:5,000), tubulin (Sigma, T5168; 1:10,000), IL-6 (R&D Systems, MAB2061; 1:50), IL-8 (R&D systems, MAB208; 1:100), ATM (Abcam, Y-170; 1:5,000), phospho-ATM (Upstate, #05-740; 1:1,000), phospho-p53 (Cell Signaling, #9284; 1;1,000), phospho-ATM/ATR STK substrates (Cell Signaling, #2851; 1:500), CHK2 (Santa Cruz Biotechnology, DC-273; 1:500) or NBS1 (Oncogene; 1:1,000). Donkey secondary antibodies conjugated to Alexa Fluor were purchased from Molecular Probes (Alexa 350, 488 and 594). Where indicated, DAPI was used to label nuclear DNA.
Labelling indexes. Cells were seeded in 4-well chamber-slides, allowed to recover for at least 48 h, and labelled with BrdU for 24 h in complete culture media. BrdU incorporation was measured using a kit and following the manufacturer's protocol (Roche BrdU labeling kit I -immunofluorescence detection).
ELISA. Conditioned media were prepared by washing cells three times in PBS and incubating them in serum-free DMEM containing antibiotics for 24 h. Conditioned media were filtered and stored at -80 ° C. The cell number was determined in every experiment. ELISAs were performed using kits and procedures from R&D Systems (IL-6 #D06050 and IL-8 #D8000C). The data were normalized to the cell number and reported as × 10 -6 pg secreted protein per cell per day.
Invasion assays. Assays were performed as described previously 6 using modified Boyden chambers with 8-micron pore filter inserts for 24-well plates (BD Bioscience). Filters were coated with 12 μl ice-cold 20% basement membrane extract (Matrigel, BD Bioscience). Epithelial cells (5 × 10 4 ) were added to the upper chamber in serum-free medium (200 μl), while the lower chamber was filled with conditioned medium (300 μl; collected over 24 h at 1 × 10 5 cells ml -1 ). After 16-24 h, epithelial cells on the underside of the filter were fixed with 2.5% glutaraldehyde in PBS and stained with 0.5% toluidine blue in 2% Na 2 CO 3 . Cells on the underside of the filter were counted using light microscopy.
Antibody arrays.
Cultures were washed and incubated in serum-free DMEM for 24 h to generate conditioned medium, which was collected before the cells were counted. Conditioned medium was filtered (0.2 mm pore), stored at -80 º C and analysed using antibody arrays (Chemicon, human arrays VI and VII, cat #AA1001CH-8), essentially according to the manufacturer's instructions but with modifications that yielded a numerical intensity for each protein detected by the array and allowed comparisons between arrays 6 . Briefly, conditioned medium was concentrated 2-to 3-fold at 4 º C (3 kD cut-off). Volumes equivalent to 2 × 10 5 cells were diluted to 1.2 ml with DMEM and mixed with 0.3 ml blocking solution. Array membranes were pre-incubated with 1.5 ml blocking solution, incubated with conditioned medium mixture (overnight at 4 º C), washed five times and then incubated with a biotin-conjugated antibody cocktail (1 h 45 min at room temperature). After five washes, detection solution containing 0.265 μCi 35 S-streptavidin (GE Healthcare; 732 Ci mmol -1 ; 0.1 mCi ml -1 ) in blocking solution was added (1 h 45 min, room temperature), followed by another five washes. Radioactivity bound to the filters was detected and quantified using a phosphorimager (Molecular Dynamics Storm 8600).
Scanned images were read using ImageQuant 1.2 software. Protein intensities were determined by taking the average of the two spots specific to each protein; all protein intensities on a given array were rescaled against the BLANK and POS spots to allow comparison between arrays. This processing yields a numerical intensity for proteins that can be readily compared between arrays. This method is linear across a large dynamic range, accurate and reliable, as reported previously 6 .
Reactive oxygen species measurement. The H2-DCFDA dye (Invitrogen, # D-399) was freshly reconstituted in 100% ethanol to a final concentration of 10 mM (1000 ×). Cells were seeded in triplicate in 12-well plates 48 h before the culture medium was removed and replaced with fresh medium containing H2-DCFDA at 10 μM. The cells were returned to a tissue culture incubator for 10 min before being rinsed with PBS and trypsinized. Trypsinized cells were resuspended in ice-cold PBS, and keep as a single cell suspension on ice until rapid analysis by FACS. As a positive control, dye-loaded cells were incubated with H 2 O 2 (0.5-1 mM) in DMEM for 10 min, which produced a consistent 6-10-fold increase in the H2-DCFDA signal. The data are reported as the fold increases in mean fluorescence intensity normalized to the fluorescence intensity of loaded untreated control cells.
Western blots. Cells were lysed in Tris-HCl (50 mM at pH 6.8), DTT (100 mM), 2% SDS and 10% glycerol. The mixture was briefly sonicated (30 s) followed by boiling (10 min) and centrifugation. Samples were loaded on 5% or 4-15% gradient tris-glycine SDS-polyacrylamide gels and separated by electrophoresis. Proteins were electroblotted overnight onto PVDF membranes and probed overnight at 4 °C in PBS 5% milk. Secondary antibodies conjugated to horseradish peroxidase were used at a dilution of 1:15000 (Jackson Immunoresearch). Blots were developed using the supersignal pico reagent (PIERCE). Figure S2 (a) Growth curve of HCA2 cells cultured until replicative senescence caused by telomere dysfunction and p53 activation. HCA2 cells at PD27-30 were infected with a retrovirus expressing hTERT (hTERT) or stimulated to rapidly enter senescence (PS) using the stimuli described in sFig1i. HCA2-hTERT cells bypassed telomere-dependent replicative senescence, which occurred in control cells around PD71. Replicatively senescent (SEN-REP) HCA2 (PD71) were infected with a lentivirus expressing GSE22 or a short hairpin RNA that reduces p53 expression by RNA interference (shP53). Loss of p53 function reverses the p53-dependent replicative senescence growth arrest, and allows cells to proliferate until crisis (caused by severely eroded telomeres). and HCA2-hTERT or HCA2-GSE22-hTERT that had undergone approximately 10 doublings in the presence of hTERT were analyzed at the indicated population doubling levels for the presence of 53BP1 foci. Note that GSE22 positive cell populations have more cells with at least one 53BP1 focus suggesting that some PDDF are telomere-independent. (e) Early passage WI38 fibroblasts cultured in a 3% oxygen atmosphere were infected with shGFP or shATM encoding lentiviruses and selected for 4 d. Proteins were extracted from untreated or X-irradiated WI38-shGFP and WI38-shATM cells (10 d after 10 Gy X-ray) and analyzed by western bloting using antibodies against either total ATM or tubulin (loading control). (f) Cells treated as in (a) were assessed for IL-6 secretion by analyzing CM collected over a 24 h interval using ELISA. The data are reported as fold change over untreated WI38-shGFP controls. Error bars show the S.D. from 3 independent measurements. (g) Damaged-induced senescent HCA2 (5 d after 10 Gy X-Ray) or PD50 HCA2-GSE22 cells were left untreated or infected with lentishATM12 and let recover for 5d. CM were collected over the next 24 h and analyzed for IL-6 using antibody arrays as in Fig. 5 . The data are reported as fold IL-6 secretion compared to control irradiated HCA2 cells. Note that shATM12 reduces IL-6 secretion both in unmodified HCA2 and in HCA2-GSE22 cells, which have dysfunctional p53. (h) HCA2 cells were either untreated (HCA2), infected with an insertless lentivirus (HCA2-vector) or infected with lentiviruses expressing oncogenic RAS and shRNAs directed against GFP (shGFP2) or ATM (shATM2). After recovery and appropriate selection (10 d), whole cell lysates were analyzed by western blotting for the presence of the indicated proteins. Ponceau staining shows the total proteins loaded on the gel. (i) Model for cytokine response to DDR signaling and chromatin stress. Repairable DNA damage triggers a DDR that transiently prevents cell proliferation while the DNA damage is repaired. Irreparable DNA damage signals through PDDF, which provide persistent DDR signaling.
The persistent DDR signals require the ATM, NBS1, and CHK2 proteins, which independently maintain the p53-dependent senescence growth arrest and the p53-independent cytokine response.
Figure S4
Examples of representative fields imaged from the frozen section tissue array and quantified using the cell profiler software.
Normal tissue
Tumor tissue 
